Breast Pathology and Cancer Diagnosis

Industries and Investors Meet

Submit Abstract Register Now

Breast Cancer being prevalent among various types of cancer, the drug market has driven up. But there are factors, which can hinder the drug market like the risk of failure of cancer drugs and therapies, side effects of cancer therapies, high cost of drug development and cost of research in this area. Breast cancer is becoming the most common cause of death of women. The girls and young age women are at high risk of cancer-causing agents. Research in field of advanced cancer drugs and personalized medicine provides opportunities to the companies in developed and developing countries in the area of pharmaceuticals and biotechnology.